Treatments
498 articles
Blood-Based Test Predicts What Drugs May Work Best
Dr. Kenneth Yu is testing a blood-based assay that looks at which types of chemotherapies will work best for each pancreatic cancer patient.
Large Phase III Global Trial Targets Cancer Metabolism
Dr. Philip Philip focuses on disrupting cancer cell metabolism with devimistat, now in a phase III global clinical trial.
Claudin May Be the Next Big Target in Pancreatic Cancer Treatment
Dr. Wungki Park leads a trial that uses a monoclonal antibody to target a protein that is common in pancreatic cancer.
KRYSTAL-1 Trial Shows Promising Activity in Pancreas and Other GI Cancers
Dr. Tanios Bekaii-Saab reports promising results of the KRYSTAL-1 trial, which targets a KRAS mutation common to pancreatic cancer.
Let’s Win Launches Online Video Series Featuring Long-Term Pancreatic Cancer Survivors
Meet long-term survivors of pancreatic cancers, in our new Survivors Video Series. The introductory video was launched in January at a cancer symposium.
Let’s Win! Pancreatic Cancer Unveils Spanish-Language Website To Connect Latinos With Pancreatic Cancer Information, Resources, And Community
Let’s Win! Pancreatic Cancer announces a Spanish-language platform to connect the Latino community to pancreatic cancer resources in Spanish.
Another Chance at Life
Molecular profiling of long-term survivor Roy Vinke’s tumor and found a mismatch repair deficiency, which changed his treatment.
Let’s Win! Pancreatic Cancer Survivors Series—Year Four
Our inspiring Survivors video series is entering Year Four. Meet more long-term survivors as well as researchers working for new treatments.
I’m Going to Beat This
Amy Zaterman is a long-term survivor who relied on her mother for support during treatment for stage IV pancreatic neuroendocrine cancer.
Let’s Win! Pancreatic Cancer Survivors Series—Year Three
Let’s Win kicks off Year Three of its Survivors Series of videos. The 2020 videos will feature patients with genetic mutations and more researchers.
An Army of Investigators—Pancreatic Cancer Doctors and Researchers
The doctors and researchers at Dana-Farber Cancer Institute and the Koch Institute for Integrative Cancer Research at MIT are working hard to develop new treatments for pancreatic cancer.
Find Treatment Options
In Find Treatment Options, oncologists and genetic counselors discuss treatments and the importance of genetic testing.
Urinary Tract Scans Lead to My Diagnosis
Ellen Robbins has the BRCA2 mutation, and that allowed her to participate in a clinical trial for her pancreatic cancer.
Meet the Researcher: Jeffrey Patterson-Fortin, M.D., Ph.D.
Researcher Dr. Jeffrey Patterson-Fortin focuses on DNA damage repair as he looks for better pancreatic cancer treatments.
Testing a New Immunotherapy Combo in Advanced Pancreatic Cancer
Researchers are testing an approved immunotherapy drug with a new drug that works on T cells to make it more effective for pancreatic cancer.